Navigation Links
Access Pharmaceuticals Presents ProLindac(TM) Data at the AACR-NCI-EORTC Symposium 2008
Date:10/21/2008

- ProLindac Is Safe And Active in Recurrent Ovarian Cancer; Unique Design Simulates 4-Day Continuous Infusion -

DALLAS, Oct. 21 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP) announced today that three posters describing significant recent results of the company's proprietary polymer DACH platinum prodrug, ProLindac, in clinical and preclinical studies are being presented this week at a major international oncology conference held in Geneva, Switzerland.

The clinical poster highlights results from the multi-center Phase 2 recurrent ovarian cancer trial in France where the level of anti-cancer activity of ProLindac in a heavily-pretreated patient population compares favorably to previously published results of single agent oxaliplatin in patients that had less pretreatment. These promising efficacy results were obtained without significant toxicity or other significant side-effects. The two preclinical posters, describing studies performed by Access collaborators at prominent Institutes in France, demonstrate the potential benefits of ProLindac over current platinum therapies: one highlights the observation that ProLindac uses albumin as a carrier, slowing blood clearance, which provides for a sustained tumor exposure to platinum. The other poster highlights that the antiproliferative effects of ProLindac are associated with an increase in expression of p21, a gene associated with cell cycle control.

"The latest results from our clinical study in advanced ovarian cancer patients continue to demonstrate that ProLindac is active in ovarian cancer with mild side-effects," stated David P. Nowotnik, Access' Senior Vice President Research and Development. "The two preclinical posters show that, mechanistically, ProLindac is similar to the approved DACH platinum compound, oxaliplatin, while benefiting from Access' proprietary polymer targeting technology. Our unique design enables targeted delivery of higher lev
'/>"/>

SOURCE Access Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Bend Research Offers Broad Access to Drug-Delivery Solutions
2. Concentric Medical Launches Distal Access Catheter
3. Bumrungrad International Hospital Makes Treatment Costs Available to Public - Bumrungrad International Offers Free Online Access to Actual Costs of 45 Procedures
4. Access to Physicians Is Consumers Highest Priority When Choosing a Health Plan, According to New Study
5. SAGE-Hindawi launch new open-access journal in dental biomechanics
6. Proposed Assisted Living Regulations Would Allow Facilities to Rent Inaccessible Rooms to Persons Who Use Wheelchairs or Walkers
7. ICERx.org Activated to Provide Emergency Access to Prescription Medication Information for Hurricane Ike Evacuees
8. New Vascular Access Medical Devices Launched by Navilyst Medical
9. Gulf Coast Dialysis Caregivers, Volunteers Brace for Hurricane Ike; Prepare to Maintain Power, Continued Access for Patients to Life-Saving Treatment
10. Young African-American Males Face Mental Health Crisis; Experts Call For New Treatment Strategies and Better Access to Care
11. Autovan Donates Wheelchair-Accessible Van; Brings Greater Mobility to Facility in Rochester, New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2015)... 26, 2015 With the FCPX LUT B&W ... editors can quickly and easily add desaturated color grades ... a mathematical formula for modifying an image. The LUT changes ... table. This pack comes with 60 black and white CUBE ... contemporary black and white films. With the FCPX LUT ...
(Date:4/26/2015)... In an article published last month in ... biomechanics occurring during the use of handheld electronic devices such ... that use of a tablet increases mechanical demand on neck ... more than when the neck is in a neutral position. ... pointing out the potential hazards of overuse of mobile technology ...
(Date:4/25/2015)... Diversified Communications has announced the launch ... Integrative Healthcare Symposium Canada, as it’s titled, will ... Sheraton Parkway Toronto North in Ontario. , The ... most anticipated events of the year and will ... event aims to gather multi-disciplined practitioners from all ...
(Date:4/25/2015)... New York, New York (PRWEB) April 25, 2015 ... http://www.vaginalmeshlawsuit2015.com/ ) established for vaginal mesh lawsuits filed ... in the U.S. District Court, Southern District of ... April 9th, a Scheduling Conference was convened that ... the Plaintiffs’ Master Long Form Complaint. The Order ...
(Date:4/25/2015)... Gardant Management Solutions will lead ... operations, and sales and marketing at the LeadingAge ... be held from April 29 through May 1 ... largest eldercare association in Illinois. The statewide association ... adults, including senior housing, assisted living and supportive ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios, a FCPX Effects Developer, Announced the Release of FCPX LUT B&W 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4Health News:Integrative Healthcare Event launching in Canada 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 2Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 3Health News:C.R. Bard Vaginal Mesh Lawsuit News: Federal Litigation Issues New Pretrial Order Following Submission of Amended Responses to Master Complaint 4Health News:Gardant Management Solutions Staff Shares Operational Expertise 2
... EAST LANSING, Mich. Curcumin, a compound found in ... of a protein involved in Parkinson,s disease, says a ... led by Basir Ahmad, an MSU postdoctoral researcher, demonstrated ... cause of clumping, or aggregation, which is the first ...
... March 15, 2012, the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) celebrated ... for all employees in the Technische Sammlungen Dresden ... HZDR,s outstanding scientific achievements of the last year ... Mller-Steinhagen, Rector of the TU Dresden [Dresden University ...
... (LPS) has been found to elevate amyloid beta (Aβ) ... in learning. "We have found that after ... LPS administration) mice showed significant elevation in Aβ levels ... biology at Texas Christian University in Fort Worth. ...
... in St. Louis have shown that a new drug makes ... of the white blood cells. Instead of attacking these cells ... marrow and into the bloodstream, where they are more vulnerable ... leukemia cells from the blood," says Geoffrey L. Uy, MD, ...
... off, one in a white judogi (the traditional judo uniform) ... and lock arms, in what looks like an awkward dance, ... the mat. Judo and mixed martial arts have become ... taken note. The two fighters were actually filmed as part ...
... (Philadelphia) Intervention by peer mentors has a statistically significant ... diabetes, according to a study by researchers at the Perelman ... Philadelphia VA Center for Health Equity Research and Promotion (CHERP). ... 20th issue of the Annals of Internal Medicine. ...
Cached Medicine News:Health News:Curcumin shows promise in attacking Parkinson's disease 2Health News:Dresden's Helmholtz Center celebrates anniversary and presents HZDR awards 2Health News:Dresden's Helmholtz Center celebrates anniversary and presents HZDR awards 3Health News:Drug makes leukemia more vulnerable to chemo 2Health News:Drug makes leukemia more vulnerable to chemo 3Health News:Scientists measure how energy is spent in martial arts 2Health News:Penn researchers find mentoring provides health benefits for African American veterans with diabetes 2Health News:Penn researchers find mentoring provides health benefits for African American veterans with diabetes 3
(Date:4/24/2015)...  Span-America Medical Systems, Inc. (NASDAQ:  SPAN) announced ... second quarter results on Thursday, April 30, after the ... will conduct a conference call at 10:00 a.m. ... financial and operating results for the second quarter ended ... conference call will be available online at ...
(Date:4/24/2015)... 24, 2015 Research and Markets ... addition of the "Lab Accessories Market ... Reservoir/Valve/Tubing/Wash Station) & End User (OEM/Biotechnology & ... to 2020" report to their offering. ... is expected to reach $504.7 million by ...
(Date:4/24/2015)... 24, 2015 The National Institute of ... National Institutes of Health [NIH])  provided grants totaling ... for the development of diagnostic tests for antibiotic-resistant ... at U.S. health facilities , the NIAID and ... multiplexed and effective tests using alternative methods to ...
Breaking Medicine Technology:Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3Kalorama: NIAID Rewards HAI Innovators with Grants 2Kalorama: NIAID Rewards HAI Innovators with Grants 3Kalorama: NIAID Rewards HAI Innovators with Grants 4
... Reportlinker.com announces that a new market ... , Reportlinker Adds Global Medical ... Sales Strategies and the Impact of Recession ... , Summary , "Global ...
... Corp. (TSX, FSE: HBP / OTCQX: HXBPF) today announced ... L-DOS47 product development programs following pre-investigational new drug ("pre-IND") ... , Helix requested the pre-IND meetings in order to ... filings with the FDA. The meeting on Topical Interferon ...
Cached Medicine Technology:Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 2Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 3Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 4Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 5Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 6Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 7Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 8Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 9Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 10Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 11Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 12Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 13Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery 14Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 2Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 3Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 4Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 5Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 6Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 7Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA 8
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: